Genomic Health Inc (GHDX) - Medical Equipment - Deals and Alliances Profile

Genomic Health Inc (GHDX) - Medical Equipment - Deals and Alliances Profile


  • Products Id :- GDME16224D
  • |
  • Pages: 55
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The company's commercial product portfolio comprises Onco type DX breast cancer test, Onco type DX colon cancer test, Onco type DX prostate cancer test and Oncotype SEQ Liquid Select liquid biopsy mutation panel. Genomic Health develops these products using its Oncotype IQ Genomic Intelligence Platform, a technology which uses RT-PCR approach to improve cancer treatment decisions. The company has operations in North America, Europe and Asia through direct offices, subsidiaries and distributors. Genomic Health is headquartered in Redwood City, California, the US.

Genomic Health Inc (GHDX)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Genomic Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Genomic Health Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Genomic Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Genomic Health Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Genomic Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Genomic Health Inc, Medical Equipment, Deal Details 12

Venture Financing 12

Epic Sciences Raises USD52 Million in Series E Financing 12

Epic Sciences Raises USD40 Million in Series D Venture Financing 14

InVitae Raises USD120 Million in Series F Venture Financing 16

Invitae Raises USD 40 Million In Series E Financing 18

Partnerships 20

Genomic Health Enters into Licensing Agreement with Cleveland Diagnostics 20

Genomic Health Enters into Licensing Agreement with Biocartis 21

New England Biolabs Enters into Licensing Agreement with Genomic Health for Ribosomal RNA Depletion Technology 22

Genomic Health Enters Into In-Licensing Agreement With Almac To Develop And Commercialize Anthracycline Chemotherapy Benefit Test 23

NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype DX Tests 25

Genomic Health Enters into Research Agreement with Janssen Pharma 26

Genomic Health and Epic Sciences Enter into Distribution Agreement 27

Philips Electronics Enters into Agreement with Genomic Health 28

Specialised Therapeutics Enters Into Distribution Agreement With Genomic Health For Oncotype DX Test 29

Genomic Health Enters Into Co-Development Agreement With OncoMed Pharma 30

Equity Offering 31

Biocartis Group Raises USD4 Million in Private Placement 31

Genomic Health Files Registration Statement For Public Offering Of Shares To Raise Up To USD 334 Million 32

Genomic Health Inc-Key Competitors 33

Genomic Health Inc-Key Employees 34

Genomic Health Inc-Locations And Subsidiaries 35

Head Office 35

Other Locations & Subsidiaries 35

Recent Developments 36

Financial Announcements 36

Aug 02, 2018: Genomic Health reports second quarter 2018 financial results 36

May 02, 2018: Genomic Health Reports First Quarter 2018 Financial Results 38

Mar 08, 2018: Genomic Health Announces 2017 Fourth Quarter and Year-end Financial Results, Provides 2018 Financial Outlook 40

Nov 08, 2017: Genomic Health Announces Third Quarter 2017 Financial Results and Reports Recent Business Progress 42

Aug 01, 2017: Genomic Health Announces Second Quarter 2017 Financial Results and Reports Recent Business Progress 44

May 09, 2017: Genomic Health Announces First Quarter 2017 Financial Results and Reports Recent Business Progress 46

Feb 14, 2017: Genomic Health Announces 2016 Fourth Quarter and Year-End Financial Results, Provides 2017 Financial Outlook 48

Product News 50

Jun 02, 2017: Genomic Health Presents Data Further Demonstrating Ability of Oncotype DX Tests to Optimize Outcomes in Patients Across Cancer Types 50

May 30, 2017: Genomic Health Announces Presentation of Eight Oncotype DX Studies at the 2017 American Society of Clinical Oncology Annual Meeting Reinforcing Unique Impact Across Cancer Types 52

Appendix 55

Methodology 55

About GlobalData 55

Contact Us 55

Disclaimer 55

List of Figures

Genomic Health Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Genomic Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Genomic Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Genomic Health Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Genomic Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Genomic Health Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Genomic Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Genomic Health Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

List of Tables

Genomic Health Inc, Medical Equipment, Key Facts, 2017 2

Genomic Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Genomic Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Genomic Health Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Genomic Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Genomic Health Inc, Deals By Market, 2012 to YTD 2018 9

Genomic Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Epic Sciences Raises USD52 Million in Series E Financing 12

Epic Sciences Raises USD40 Million in Series D Venture Financing 14

InVitae Raises USD120 Million in Series F Venture Financing 16

Invitae Raises USD 40 Million In Series E Financing 18

Genomic Health Enters into Licensing Agreement with Cleveland Diagnostics 20

Genomic Health Enters into Licensing Agreement with Biocartis 21

New England Biolabs Enters into Licensing Agreement with Genomic Health for Ribosomal RNA Depletion Technology 22

Genomic Health Enters Into In-Licensing Agreement With Almac To Develop And Commercialize Anthracycline Chemotherapy Benefit Test 23

NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype DX Tests 25

Genomic Health Enters into Research Agreement with Janssen Pharma 26

Genomic Health and Epic Sciences Enter into Distribution Agreement 27

Philips Electronics Enters into Agreement with Genomic Health 28

Specialised Therapeutics Enters Into Distribution Agreement With Genomic Health For Oncotype DX Test 29

Genomic Health Enters Into Co-Development Agreement With OncoMed Pharma 30

Biocartis Group Raises USD4 Million in Private Placement 31

Genomic Health Files Registration Statement For Public Offering Of Shares To Raise Up To USD 334 Million 32

Genomic Health Inc, Key Competitors 33

Genomic Health Inc, Key Employees 34

Genomic Health Inc, Other Locations 35

Genomic Health Inc, Subsidiaries 35

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Genomic Health Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17835
Site License
USD 500 INR 35670
Corporate User License
USD 750 INR 53505

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com